Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Nicola A Hanania; Jorge F Maspero; David M G Halpin; David J Jackson; Reynold A Panettieri; Mario Castro; Cristian Domingo Ribas; Nadia Daizadeh; Rebecca Gall; Juby A Jacob-Nara; Benjamin Ortiz; Michel Djandji; Paul J Rowe; Yamo Deniz

doi:10.2147/JAA.S354013

Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

Nicola A Hanania, Jorge F Maspero, David M G Halpin, David J Jackson, Reynold A Panettieri, Mario Castro, Cristian Domingo Ribas, Nadia Daizadeh, Rebecca Gall, Juby A Jacob-Nara, Benjamin Ortiz, Michel Djandji, Paul J Rowe, Yamo Deniz

Departament de Medicina

Producció científica: Contribució a revista › Article › Recerca › Avaluat per experts

1 Citació (Scopus)

Idioma original	Anglès
Pàgines (de-a)	851-854
Nombre de pàgines	4
Revista	Journal of Asthma and Allergy
Volum	15
DOIs	https://doi.org/10.2147/JAA.S354013
Estat de la publicació	Publicada - 2022

Accés al document

10.2147/JAA.S354013

https://ddd.uab.cat/record/280774

Altres arxius i enllaços

Link to publication in Scopus

Com citar-ho

Hanania, N. A., Maspero, J. F., Halpin, D. M. G., Jackson, D. J., Panettieri, R. A., Castro, M., Domingo Ribas, C., Daizadeh, N., Gall, R., Jacob-Nara, J. A., Ortiz, B., Djandji, M., Rowe, P. J., & Deniz, Y. (2022). Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation. Journal of Asthma and Allergy, 15, 851-854. https://doi.org/10.2147/JAA.S354013

@article{ea8ddfad76204af18196204f400df78e,

title = "Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation",

author = "Hanania, \{Nicola A\} and Maspero, \{Jorge F\} and Halpin, \{David M G\} and Jackson, \{David J\} and Panettieri, \{Reynold A\} and Mario Castro and \{Domingo Ribas\}, Cristian and Nadia Daizadeh and Rebecca Gall and Jacob-Nara, \{Juby A\} and Benjamin Ortiz and Michel Djandji and Rowe, \{Paul J\} and Yamo Deniz",

note = "Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT02414854. Medical writing/editorial assistance was provided by Natalia Crespo, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals, Inc., according to the Good Publication Practice guideline.",

year = "2022",

doi = "10.2147/JAA.S354013",

language = "English",

volume = "15",

pages = "851--854",

journal = "Journal of Asthma and Allergy",

issn = "1178-6965",

publisher = "Dove Medical Press Ltd.",

}

Hanania, NA, Maspero, JF, Halpin, DMG, Jackson, DJ, Panettieri, RA, Castro, M, Domingo Ribas, C, Daizadeh, N, Gall, R, Jacob-Nara, JA, Ortiz, B, Djandji, M, Rowe, PJ & Deniz, Y 2022, 'Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation', Journal of Asthma and Allergy, vol. 15, pàg. 851-854. https://doi.org/10.2147/JAA.S354013

TY - JOUR

T1 - Improvement in Lung Function with Dupilumab Does Not Predict Its Effects on Reducing Asthma Exacerbation

AU - Hanania, Nicola A

AU - Maspero, Jorge F

AU - Halpin, David M G

AU - Jackson, David J

AU - Panettieri, Reynold A

AU - Castro, Mario

AU - Domingo Ribas, Cristian

AU - Daizadeh, Nadia

AU - Gall, Rebecca

AU - Jacob-Nara, Juby A

AU - Ortiz, Benjamin

AU - Djandji, Michel

AU - Rowe, Paul J

AU - Deniz, Yamo

N1 - Funding Information: Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifier: NCT02414854. Medical writing/editorial assistance was provided by Natalia Crespo, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals, Inc., according to the Good Publication Practice guideline.

PY - 2022

Y1 - 2022

UR - https://www.scopus.com/pages/publications/85134655921

U2 - 10.2147/JAA.S354013

DO - 10.2147/JAA.S354013

M3 - Article

C2 - 35789920

SN - 1178-6965

VL - 15

SP - 851

EP - 854

JO - Journal of Asthma and Allergy

JF - Journal of Asthma and Allergy

ER -